Prevalence of Low Vitamin D in Patients with Breast Cancer in a Predominantly Hispanic Population at the American-Mexican Border

References

• Thanasitthichai S, Chaiwerawattana A, and Prasitthipayong A: Association of Vitamin D level with clinicopathological features in breast cancer. Asian Pac J Cancer Prev 16(12), 4881–4883, 2015.
   PubMedGoogle Scholar
• Ness RA, Miller DD, and Li W: The role of vitamin D in cancer prevention. Chin J Nat Med 13(7), 481–497, 2015.
   PubMed Web of Science ®Google Scholar
• Martin-Herranz A, and Salinas-Hernandez P: Vitamin D supplementation review and recommendations for women diagnosed with breast or ovary cancer in the context of bone health and cancer prognosis/risk. Crit Rev Oncol Hematol 96(1), 91–99, 2015.
   PubMed Web of Science ®Google Scholar
• Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, et al.: Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903, 2014.
   PubMed Web of Science ®Google Scholar
• Grant WB, and Mohr SB: Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 19(7), 446–454, 2009.
   PubMed Web of Science ®Google Scholar
• Jacobs ET, Kohler LN, Kunihiro AG, and Jurutka PW: Vitamin D and colorectal, breast, and prostate cancers: A review of the epidemiological evidence. J Cancer 7(3), 232–240, 2016.
   PubMed Web of Science ®Google Scholar
• Janbabai G, Shekarriz R, Hassanzadeh H, Aarabi M, and Borhani SS: A survey on the relationship between serum 25-hydroxy vitamin D level and tumor characteristics in patients with breast cancer. Int J Hematol Oncol Stem Cell Res 10(1), 30–36, 2016.
   PubMedGoogle Scholar
• Abbas S, Chang-Claude J, and Linseisen J: Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer 124(1), 250–255, 2009.
   PubMed Web of Science ®Google Scholar
• Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, et al.: Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103(3–5), 708–711, 2007.
   PubMed Web of Science ®Google Scholar
• De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, et al.: Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol 15(1), 23–34, 2014.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7), 1911–1930, 2011.
   PubMed Web of Science ®Google Scholar
• Taksler GB, Cutler DM, Giovannucci E, and Keating NL: Vitamin D deficiency in minority populations. Public Health Nutr 18(3), 379–391, 2015.
   PubMed Web of Science ®Google Scholar
• Sumbul AT, Sezer A, Kavvasoglu G, Batmaci CY, Yengil E, et al.: Low serum levels of vitamin D in metastatic cancer patients: a case-control study. Med Oncol 31(3), 861, 2014.
   PubMed Web of Science ®Google Scholar
• Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, et al.: Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) 2(6), 598–604, 2009.
   PubMed Web of Science ®Google Scholar
• Hauser K, Walsh D, Shrotriya S, and Karafa M: Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg? Support Care Cancer 22(7), 1931–1939, 2014.
   PubMed Web of Science ®Google Scholar
• Deeb KK, Trump DL, and Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7(9), 684–700, 2007.
   PubMed Web of Science ®Google Scholar
• Churilla TM, Lesko SL, Brereton HD, Klem M, Donnelly PE, et al.: Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case-control study. BMJ Open 1(2), e000397, 2011.
   PubMed Web of Science ®Google Scholar
• Sheng L, Anderson PH, Turner AG, Pishas KI, Dhatrak DJ, et al.: Identification of vitamin D target genes in human breast cancer tissue. J Steroid Biochem Mol Biol 164, 90–97, 2016.
   PubMed Web of Science ®Google Scholar
• Bauer SR, Hankinson SE, Bertone-Johnson ER, and Ding EL: Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) 92(3), 123–131, 2013.
   PubMed Web of Science ®Google Scholar
• Feldman D, Krishnan AV, Swami S, Giovannucci E, and Feldman BJ: The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14(5), 342–357, 2014.
   PubMed Web of Science ®Google Scholar
• Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, et al.: Molecular mechanisms of vitamin D action. Calcified Tissue Int 92(2), 77–98, 2013.
   PubMed Web of Science ®Google Scholar
• Mohr SB, Gorham ED, Kim J, Hofflich H, and Garland CF: Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res 34(3), 1163–1166, 2014.
   PubMed Web of Science ®Google Scholar
• Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, and Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85(6), 1586–1591, 2007.
   PubMed Web of Science ®Google Scholar
• Walentowicz-Sadlecka M, Grabiec M, Sadlecki P, Gotowska M, Walentowicz P, et al.: 25(OH)D3 in patients with ovarian cancer and its correlation with survival. Clin Biochem 45(18), 1568–1572, 2012.
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Ennis M, Pritchard KI, Koo J, and Hood N: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27(23), 3757–3763, 2009.
   PubMed Web of Science ®Google Scholar
• Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, et al.: Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 13(4), R74, 2011.
   PubMed Web of Science ®Google Scholar
• Li M, Chen P, Li J, Chu R, Xie D, et al.: Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 99(7), 2327–2336, 2014.
   PubMed Web of Science ®Google Scholar
• Villaseñor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, et al.: Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control 24(4), 759–767, 2013.
   PubMed Web of Science ®Google Scholar
• Garland CF, Gorham ED, Mohr SB, and Garland FC: Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19(7), 468–483, 2009.
   PubMed Web of Science ®Google Scholar
• Taksler GB, Cutler DM, Giovannucci E, Smith MR, and Keating NL: Ultraviolet index and racial differences in prostate cancer incidence and mortality. Cancer 119(17), 3195–3203, 2013.
   PubMed Web of Science ®Google Scholar
• Weishaar T, and Vergili JM: Vitamin D status is a biological determinant of health disparities. J Acad Nutr Diet 113(5), 643–651, 2013.
   PubMed Web of Science ®Google Scholar
• Tretli S, Schwartz GG, Torjesen PA, and Robsahm TE: Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23(2), 363–370, 2012.
   PubMed Web of Science ®Google Scholar
• Datta M, and Schwartz GG: Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy. Crit Rev Oncol Hematol 88(3), 613–624, 2013.
   PubMed Web of Science ®Google Scholar
• Maxmen A: Nutrition advice: the vitamin D-lemma. Nature 475(7354), 23–25, 2011.
   PubMed Web of Science ®Google Scholar
• Heaney RP: What is vitamin D insufficiency? And does it matter? Calcified Tissue Int 92(2), 177–183, 2013.
   PubMed Web of Science ®Google Scholar